Title
Category
Credits
Event date
Cost
  • Research to Practice
  • 1.00 Participation
$0.00
This lecture will provide an overview of the burden and outcomes of COVID-19 among patients living with cancer. We will also review the impact of the pandemic on cancer care delivery, and emerging data regarding vaccination safety and efficacy.
  • Research to Practice
  • 1.00 Participation
$0.00
Genitourinary malignancies will account for approximately 20% of newly diagnosed cancers in 2021. Recent research advances in prostate, bladder, and kidney cancers utilizing new biomarkers and imaging tools, radiolabeled therapy, targeted therapy, immunotherapy and antibody-drug conjugates have led to new management approaches associated with significant improvements in patient outcomes.
  • Research to Practice
  • 1.00 Participation
$0.00
Immune Thrombocytopenic Purpura and Thrombotic Thrombocytopenic Purpura are both autoimmune conditions leading to low platelets, though the mechanism by which the platelets are consumed differs.  The lecture will update viewers on new therapies for the treatment of ITP and TTP
  • Patient Centered Care
  • 1.00 Participation
$0.00
This is a case-based lecture to cover the common side effects and rare but important side effects of check point inhibitors and other immunotherapy agents.
  • Patient Centered Care
  • 1.00 Participation
$0.00
This talk aims to provide a general background on the breadth and application of genetic testing in cancer patients. We will also provide strategies for communicating with patients about the necessity and utilization of testing, by presenting sample patient cases to demonstrate these approaches.
  • Patient Centered Care
  • 1.00 Participation
$0.00
Drs. Stephanie Wheeler and Don Rosenstein will discuss current concepts related to “financial toxicity” and how this applies to cancer care delivery in North Carolina. Current research including interventions in development to mitigate financial toxicity will also be reviewed.
  • Patient Centered Care
  • 1.00 Participation
$0.00
Dr. Hyman Muss will discuss recommendations related to specific needs of older patients with cancer. Updates will be presented regarding the implementation of the geriatric assessment into routine cancer care, as well as management strategies that are identified based on the results of the geriatric assessment.
  • Patient Centered Care
  • 1.00 Participation
$0.00
Terri Phoenix, PhD, and Patricia Morfeld, RN, BSN, OCN, will discuss physical and psychological concerns of transgender patients who have active cancer or who are survivors. Session will address relevant terminology, recommended practices, and resources for continuing education.
  • Patient Centered Care
  • 1.00 Participation
$0.00
Dr. Michelle Gardiner will discuss topics relevant to common and problematic side effects of anti-cancer treatments.  Issues to be covered include; handling of acute infusion reactions, prevention and treatment of peripheral neuropathy, and the importance of recognizing and evaluating cancer-related fatigue in patients.
  • Research to Practice
  • 1.00 Participation
$0.00
CAR-T therapy is expanding as a therapeutic option both in clinical trials and FDA approved commercial products for cancer patients.  This lecture will review the current treatments and their use in patients with hematologic malignancies.

Pages